tiprankstipranks
Tourmaline Bio (TRML)
NASDAQ:TRML
US Market
Holding TRML?
Track your performance easily

Tourmaline Bio (TRML) Income Statement

467 Followers

Tourmaline Bio Income Statement

Last quarter (Q3 2024), Tourmaline Bio's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Tourmaline Bio's net income was $-20.18M. See Tourmaline Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
----$ 0.00$ 0.00
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 59.28M$ 45.41M$ 19.70M$ 47.51M$ 22.68M$ 18.38M
Operating Income
$ -59.82M$ -45.41M$ -19.70M$ -47.51M$ -22.68M$ -18.38M
Net Non Operating Interest Income Expense
--$ 2.58M$ -326.00K$ -23.00K$ 223.00K
Other Income Expense
$ -9.06M$ 3.29M$ 643.00K$ 65.00K--
Pretax Income
$ -64.03M$ -42.12M$ -19.70M$ -47.90M$ -22.71M$ -18.16M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -49.19M$ -42.12M$ -19.70M$ -47.90M$ -22.71M$ -18.16M
Basic EPS
$ 15.33$ -8.87$ -17.90$ -16.40$ -1.07$ -0.86
Diluted EPS
$ 15.33$ -8.87$ -17.90$ -16.40$ -1.07$ -0.86
Basic Average Shares
$ 81.89M$ 4.75M$ 4.12M$ 2.91M$ 21.19M$ 21.19M
Diluted Average Shares
$ 81.89M$ 4.75M$ 4.12M-$ 21.19M$ 21.19M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 59.28M$ 45.41M$ 19.70M$ 47.51M$ 22.68M$ 18.38M
Net Income From Continuing And Discontinued Operation
$ -63.84M$ -42.12M$ -19.70M$ -47.83M$ -22.71M$ -18.16M
Normalized Income
$ -37.29M--$ -37.10M$ -22.71M$ -18.16M
Interest Expense
------
EBIT
$ -68.15M$ -42.12M$ -19.70M$ -47.90M$ -22.68M$ -18.38M
EBITDA
$ -63.97M$ -41.97M$ -19.70M$ -46.85M$ -22.24M$ -18.00M
Currency in USD

Tourmaline Bio Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis